Noninvasive fetal RHD testing is emerging as a standard of care: insights from a global survey
Alloimmunization against Rhesus D (RhD) is the leading cause of hemolytic disease of the fetus and...
Smarter prophylaxis: How RHD testing protects patients and resources
The supply of anti-D immunoglobulin, a prophylactic cornerstone of maternal care, has come under...
Top performance at high-throughput: Devyser RHD maintains high sensitivity within an automated, high-throughput setting in Sahlgrenska University Hospital Study
Over the past decade, there has been a wealth of research investigating the ideal approach to RHD...
Approval of Devyser’s RHD product in Canada
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...